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This thesis was done in the research groups of Kalervo Hiltunen and Alexander 
Kastaniotis at the Oulu University in the Department of Biochemistry. The aim of 
the study was to purify TAP tagged Rpm2p protein from yeast cell extracts or 
mitochondrial extracts with IgG columns with a mildly modified procedure in 
wildtype and the mtFAS deficient etr1Δ strains to asses Rpm2p palmitoylation 
and physical interactions. 
 
The first purification was made using solubilised extract from 2-3 g of cells and 
the second using purified mitochondria. Both were then continued in a similar 
manner by binding the TAP tagged target proteins in IgG columns and then 
eluting them with self made TEV protease. Finally the proteins were analysed 
with SDS-PAGE and MALDI-TOF mass spectrometry. 
 
Neither of these purifications worked out for the protein of main interest. Only 
the self made TEV protease and the Gcv3p protein of the control strain could be 
identified. Nevertheless, the fact that the Gcv3p could be purified proves that 
the purification should work in general and this work will provide a good starting 
point for optimization and further investigations. 
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Tämä opinnäytetyö tehtiin Kalervo Hiltusen ja Alexander Kastaniotiksen 
tutkimusryhmissä Oulun yliopiston biokemian laitoksella. Työn tavoitteena oli 
puhdistaa mitokondriaalinen Rpm2p proteiini TAP-affiniteettikromatografisesti 
kahta erilaista uutetta käyttäen. Ensimmäinen puhdistus tehtiin uuttamalla 
proteiinit 2-3 grammasta hiivasoluja ja toinen puhdistus tehtiin puhdistetuista 
mitokondrioista. Molempia puhdistuksia jatkettiin tästä samalla tavoin sitomalla 
kohdeproteiinit IgG-kolonniin ja eluoimalla ne itse tuotetulla TEV proteaasilla. 
Proteiinit analysoitiin vielä SDS-PAGElla ja MALDI-TOF -massaspektrometrillä. 
 
Kumpikaan puhdistusmenetelmistä ei toiminut kohdeproteiinin osalta ja 
ainoastaan kontrollihiivakannan proteiini Gcv3p sekä itse tuotettu TEV proteaasi 
saatiin tunnistettua massaspektrometrillä. Koska Gcv3p onnistuttiin kuitenkin 
puhdistamaan, voidaan päätellä, että puhdistusmenetelmä on kehityskelpoinen. 
Tämä työ toimiikin hyvänä lähtökohtana puhdistusmenetelmän optimoimiselle ja 
tuleville tutkimuksille. 
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1 INTRODUCTION 
Although the mitochondrion is usually regarded as the “power plant” of the cell it 
is a lot more. One of the recently recognised significant features of mitochondria 
is their ability to synthesise fatty acids. The enzyme cofactor lipoic acid  is one 
of the end products of this mitochondrial fatty acid synthesis (mtFAS) pathway. 
Other products are long-chain fatty acids which may be used for the acylation of 
proteins. 
The target protein, Rpm2p, is a membrane associated mitochondrial protein that 
is predicted to be covalently modified by acylation with palmitic acid, one of the 
end products of the mitochondrial FAS pathway. Hence, it is a protein of interest 
in the research of the physiological function of mtFAS. This protein is encoded 
in the nucleus, translated in the cytoplasm and then imported into the 
mitochondria where it forms functional complex with an RNA subunit and has 
been reported to interact with the mitochondrial translation machinery (Daoud – 
Forget – Lang 2011). 
The aim of the study was to purify TAP tagged Rpm2p from yeast cell extracts 
or mitochondrial extracts with IgG columns with a mildly modified procedure in 
wildtype and the mtFAS deficient etr1Δ strains to assess Rpm2p palmitoylation 
and physical interactions. The procedure was modified by lowering the pH in 
order to maintain the possible palmitoylation of the protein. TAP-tagged Gcv3 
was used as a control. As Gcv3p is lipoylated and required for the lipoylation of 
other enzyme complexes, it is also a protein of interest for the research of the 
Hiltunen group where the work was conducted. The cleavage of the TAP tags 
was done with self made TEV protease, an enzyme produced in and purified 
from an Escherichia coli strain with a plasmid encoding the protein. 
The work was conducted in the research groups of Kalervo Hiltunen and 
Alexander Kastaniotis at the Oulu University in the Department of Biochemistry. 
The main areas of interests within the research group are the mitochondrial fatty 
acid synthesis and its physiological significance, the role of peroxisomes and 
mitochondria in the metabolism of fatty acids and their derivatives, and acyl-
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thioester binding enzymes in metabolism and their structural enzymology. Most 
of the experiments are done using yeast and mouse as a model organism. 
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2 REVIEW OF LITERATURE 
Theoretical background on the main topics of the thesis is presented on the 
review of the literature section. General information on mitochondria, 
mitochondrial fatty acid synthesis, and covalent modification of proteins 
emphasizing on palmitoylation and myristylation are presented. 
2.1 Mitochondria and their structure 
The mitochondrial contribution to cell physiology goes far beyond its function as 
a cellular power plant that it was regarded as until the late 1980s when the 
assumption that everything important of the organelle was already known was 
questioned. In the current view, the organelle rather appears like a cellular 
conglomerate involved in various processes, generating a large number of 
essential products. The observations in recent research include aspects of 
mitochondrial fusion and fission events, linkage of mitochondrial fusion events 
to the progression of the cell cycle, mitochondrial-nuclear crosstalk, 
mitochondrial DNA replication, transcription and translation, iron-sulphur cluster 
biogenesis and the role of mitochondria in apoptosis. (Hiltunen – Chen – 
Haapalainen – Wierenga – Kastaniotis 2010b, 28) 
The mitochondrion is a very important eukaryotic organelle and has been 
essential for the evolution of complex animals. The metabolism of sugars is 
completed in the mitochondria and without them animal cells would be 
dependent on anaerobic glycolysis for all their ATP. Mitochondria also have 
their own DNA and their own apparatus for synthesis of RNA and proteins. 
(Alberts 2002, 769; Campbell 1999, 37) 
The size of higher eukaryote mitochondria varies from 2 µm to 8 µm in length 
and the diameter is typically 1 µm, which is approximately the size of many 
bacteria (Campbell 1999, 28), while yeast mitochondria are somewhat smaller 
(Shinigawa – Inouye – Onishi – Hagihara 1966). They are mobile and plastic 
organelles, constantly changing their shape and also fusing with each other and 
then separating again (Alberts 2002, 769). The number of mitochondria varies 
 10 
significantly from cell type to cell type (Scheffler 2008,16). A schematic of a 
mitochondrion is presented in figure 1. 
 
FIGURE 1. Structure of mitochondrion. (Mathews  – van Holde  – Ahern 1999) 
As seen in figure 1 mitochondria have a double membrane: an outer 
membrane, which has a fairly smooth surface and an inner membrane with 
many folds called cristae increasing the area of the membrane. These 
membranes together create two compartments inside the mitochondria, the 
internal matrix and an intermembrane space, which is much narrower than the 
inner space in the mitochondria. The two mitochondrial membranes have very 
different functions. The outer membrane contains a large amount of a transport 
protein called porin and is more permeable to molecules than the inner 
membrane. The intermembrane space therefore is chemically equivalent to the 
cytosol in terms of solutes. (Alberts 2002, 771) 
The matrix and the inner membrane that surrounds it is the scene for the major 
events in the mitochondria. By completing the metabolism of sugars in the 
mitochondria, 36 molecules of ATP are produced for each molecule of glucose 
oxidized which is remarkably more compared to the 2 molecules of ATP 
produced by glycolysis alone. Although S. cerevisiae respiration is much less 
efficient (only 16 ATP total yield from complete oxidation of glucose the yield is 
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still 8 fold higher than from glycolysis) (Rodrigues – Ludovico – Leão 2006). The 
matrix therefore contains many enzymes involved in the metabolism of pyruvate 
and fatty acids to produce acetyl-CoA and enzymes involved in the citric acid 
cycle. (Alberts 2002, 771)  
Mitochondria are able to use both pyruvate and fatty acids as fuel. These 
molecules are transported through the inner membrane and converted into 
acetyl-CoA by enzymes in the matrix. The acetyl-CoA enters then the citric acid 
cycle by which the acetyl groups are oxidized. This most importantly produces 
high-energy electrons carried by the activated carrier molecules NADH and 
FADH2. These molecules are then transported into the electron-transport chain 
which is located in the inner membrane of the mitochondrion. Via the electron-
transport chain 34 molecules of ATP is produced. (Alberts 2002, 771–773) 
2.2 Mitochondrial fatty acid synthesis 
Among the recently recognised features of mitochondrial functions is their ability 
to synthesise fatty acids. This mitochondrial fatty acid synthesis pathway 
proceeds in an acyl carrier protein-dependent manner through a discrete set of 
monofunctional enzymes (Hiltunen et al. 2010b, 28). It takes place in the 
mitochondrial matrix and follows the process of fatty acid synthesis in general 
(Kursu 2010, 17). 
The first committed step of fatty acid synthesis is the generation of malonyl-CoA 
via the condensation of acetyl-CoA and bicarbonate which is performed by 
acetyl-CoA carboxylase (ACC) (Hiltunen et al. 2010b, 38). The 
phosphopantetheine transferase (PPT) activates the apo-ACP into holo-ACP 
which is then attached to the malonyl group of malonyl-CoA by malonyl-
CoA:ACP transacylase (MCAT). The formed Malonyl-ACP is then extended to 
3-ketoacyl-ACP by an acetyl group from acetyl-CoA, acetyl-ACP or a longer 
saturated fatty acid attached to ACP. This reaction is catalysed by 3-ketoacyl-
ACP (KAS). (Hiltunen et al. 2010b, 31; Kursu 2010, 17) The 3-keto group is 
reduced to a 3-hydroxy group by 3-ketoacyl reductase (KAR) and a water 
molecule is removed by 3-hydroxyacyl-ACP dehydratase (HTD). In the last step 
the resulting enoyl group from the trans-2-enoyl-ACP is reduced to acyl-ACP 
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which is catalysed by enoyl-thioester reductase (ETR). (Kursu 2010, 17–18) 
The steps of the fatty acid synthesis in mitochondria are presented in figure 2. 
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FIGURE 2. Mitochondrial fatty acid synthesis. (Hiltunen et. al 2010a,1196; 
Hiltunen et al. 2010b, 29) 
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The end products of the mitochondrial FAS are octanoyl-ACP, medium- and 
long-chain fatty acids. These mitochondrially synthesised long-chain fatty acids, 
for example 3-hydroxymyristoyl-ACP, are possibly used for protein acylation 
which is one type of lipid modifications of proteins. The best characterised 
physiological function of the pathway is to provide the octanoyl chain (octanoyl-
ACP), a substrate, for lipoic acid synthesis which seems to be an essential 
process in mammals. The octanoyl-ACP is also one of the major products of 
this mitochondrial fatty acid synthesis pathway. (Hiltunen – Autio – Schonauer – 
Kursu – Dieckmann – Kastaniotis 2010a, 1195; Kursu 2010, 69) 
The mitochondrial pathway is best described in Saccharomyces cerevisiae and 
it is the first organism in which all the mitochondrial fatty acid synthesis 
enzymes have been characterized completely (Hiltunen et al. 2010b, 28; Kursu 
2010, 18). With the help of the research on the mitochondrial FAS in S. 
cerevisia evidence have been found to support the idea that this pathway is 
essential in many ways. If any member of the mitochondrial FAS pathway is 
deleted in S. cerevisiae it leads to a respiratory deficient phenotype, lack of 
cytochromes, and a decrease in lipoic acid, which indicates that this pathway is 
essential for mitochondrial function. (Hiltunen et al. 2010b, 28) There is also a 
possible link between the mitochondrial FAS and RNA processing in 
vertebrates. (Hiltunen et al. 2010a, 1200) 
Mitochondria of yeast cells lacking functional mitochondrial FAS appear small 
and rudimentary and exhibit a fragile, more highly branched morphology than 
mitochondria of wild type cells which indicates that the mitochondrial FAS has 
an effect on the morphology of mitochondria. It is also possible that 
mitochondrial FAS dysfunction leads to the development of disorders in 
mammals. (Hiltunen et al. 2010a, 1200) A first case of a patient suffering from 
lipoic acid deficiency has been recently published (Mayr – Zimmermann – Fauth 
– Meierhofer  – Raydmayr – Zschocke – Koch – Sperl 2011). 
As mentioned before mitochondrial FAS is essential for the synthesis of lipoic 
acids, as the synthesis of the cofactor starts from octanoic acid moieties 
produced by the mtFAS pathway. According to the existing model in yeast, an 
octanoyl group/lipoic acid is transferred to Gcv3p (the H-protein) of the glycine 
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cleavage system followed by lipoic acid synthesis. The lipoylated Gcv3p is then 
required for lipoylation of other lipoic acid-dependent enzyme complexes – 
pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase (KDH). 
(Hiltunen et al. 2010a, 1196–1198) 
Kursu (2010, 70) states in his thesis that the mitochondrial FAS pathway could 
act as the master regulator of respiratory growth via synthesis of lipoic acid 
precursors and longer fatty acids required for post-transcriptional gene 
expression. Kursu (2010, 76) also drew a conclusion that the pathway could be 
the sensor for the nutritional status of the cell by connecting acetyl-CoA 
availability to functional fatty acids. But despite all the current knowledge of the 
mitochondrial FAS pathway, not all physiologically relevant end products and 
their functions have been discovered and, thus, the physiological significance of 
the mitochondrial FAS pathway is still partly unsettled (Kursu 2010, 27). 
2.3 Lipid modifications of proteins 
Proteins are covalently modified with lipids in many ways (Nadolski & Linder 
2007, 5202). These modifications play important roles inside and outside of the 
cell and they are characterized by the identity of the lipid moiety attached, the 
nature of the covalent bond, the attachment site of the lipid on the protein and 
the enzymes catalysing the reaction involved. There are four major types of 
known lipid modifications; cholesteroylation, prenylation, glypiation and fatty 
acylation. (Martin – Beauchamp – Berthiaume 2010, 18) 
 Fatty acylation mainly consists of the addition of palmitic or myristic fatty acids 
covalently to proteins (Martin et al. 2010, 18). These long-chain fatty acids used 
in the acylation are the products of the mitochondrial FAS pathway and 
therefore emphasis will be put only to palmitoylation and myristoylation. 
2.3.1 Palmitoylation 
The attachment of the 16-carbon saturated fatty acid palmitate to an S-terminal 
cysteine residue via a thioester bond is typically referred to as palmitoylation. In 
some cases the palmitoyl moiety is linked to the N-terminal cysteine on the 
protein via an amide bond. (Martin et al. 2010, 18) S-terminal palmitoylation is 
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reversible, which makes it unique among lipid modifications (Nadolski & Linder 
2007, 5203).  It can also occur spontaneously, without enzymes involved in the 
reaction (Martin et al. 2010, 18). 
The roles of palmitoylation are diverse. According to Nadolski & Linder (2007, 
5204) the most commonly described function of palmitoylation is to increase the 
affinity of a soluble protein for membranes, which can thereby affect the 
localisation of the protein. Other functions for palmitoylation are regulation of 
protein trafficking and modulating protein stability by quality control and 
regulating protein degradation. (Nadolski & Linder, 5203–5205) 
2.3.2 Myristoylation 
Typically, myristoylation consists of the covalent addition of the 14-carbon 
saturated fatty acid myristate to the N-terminal glycine residue of the protein 
through a stable amide bond catalysed by myristoyl-CoA:protein N-
myristoyltransferase (NMT). Also various saturated and unsaturated 14-carbon 
fatty acids are found on the N-terminal glycine of proteins in myristoylation. 
Myristoylation is required for membrane binding and many myristoylated 
proteins play key roles in cellular signalling pathways. The myristoyl moiety of 
these proteins has been shown to mediate subcellular targeting, protein-protein 
and protein-membrane interactions required for the activities of these proteins. 
Another role for myristoylation is that it can participate in differential targeting to 
membranes and sub-membrane domains. (Martin et al. 2010, 18–19) 
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3 PURIFICATION AND CHARACTERISATION OF PROTEINS 
Proteins are very important molecules for life. Enzymes, which in most cases 
are proteins also, catalyse all the chemical reactions essential for life. Proteins 
are also involved in the following important functions: the import of molecules in 
and out of the cell, building of cell organelles, contracting of muscles, 
transportation of cells, the identification of the surface structure of cell, hormonal 
functions, and the formation of antibodies. (Turpeenoja 2005, 85) 
3.1 Purification of proteins in general 
Proteins not only differ by their function but also by their size, solubility, charge 
and their biological affinity. These differences are utilized when purifying 
proteins from cells or tissue. (Turpeenoja 2005, 100) 
When purifying proteins, methods that do not denature the proteins quaternary 
and tertiary structure should be used. Matters that have to be taken account, 
are the working temperature, the pH and the ion strength of the solutions used. 
Most of the proteins are very sensitive to heat: most of the soluble proteins are 
denatured when the temperature rises above +50 oC. In order to maintain the 
native structure of the protein and prevent degradation, they should be isolated 
and purified near the temperature of 0 oC. Also, repeated freezing and melting 
denatures proteins. 
Proteins are maintained native at the pH range of 5-9 and therefore buffers 
used in the purification of proteins. When purifying enzymes 
ethylenediaminetetraacetic acid (EDTA) is often added to bind divalent cations 
to inactivate cation-dependent proteases. 
In order to prevent oxidation of proteins, compounds that protect the thiol 
groups are often added, such as dithiothreitol (DTT). Also compounds, like 
saccharose and albumin that stabilise proteins can be used in the buffers. In 
cell and tissue preparations there are proteolytic enzymes that degrade 
proteins. The activity of these enzymes can be reduced by protease-inhibitors 
and by working at low temperatures. 
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At the early stages of protein purification, different types of precipitation 
methods are often used (e.g. ammonium sulphate- and acetone precipitation). 
The precipitation is based on the different solubilities of different proteins. 
Precipitations with organic solvents are done quickly and at low temperature. 
(Turpeenoja 2005, 170) 
As there are many different purification methods, an overall purification strategy 
helps to get started with the purification. A three phase purification strategy can 
be applied when purifying proteins (see figure 3). It is used as an aid for 
development of different purification processes. 
 
FIGURE 3. Preparation and three phase purification strategy (Amersham 
Pharmacia Biotech 1999) 
A specific objective is assigned to each step in the three phase strategy. The 
objectives in the capture phase are to isolate, concentrate and stabilise the 
proteins of interest. Most of the bulk impurities are removed in the intermediate 
purification phase. At this phase most of the impurities have already been 
removed except for trace amounts or substances that are closely related. These 
are removed in the last step, the polishing phase, in which the objective is to 
achieve final purity. 
Even though there are three steps in the three phase strategy, it should be 
noted that not all the strategies must have three purification steps. Some 
purifications might need less than three steps because of the high purity or the 
starting material or because the purity demands are low. On the other hand, 
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sometimes a fourth or a fifth step is required because of high purity and safety 
demands. Therefore, this is only an overall strategy which is easily modified to 
different to cases. (Amersham Pharmacia Biotech 1999, 19–20) 
3.2 Affinity chromatography 
The ability of molecules to bind to each other specifically, is used in the 
purification of biomolecules by affinity chromatography. Affinity chromatography 
is a unique purification method since it is the only technique that enables the 
purification of a biomolecule on the basis of its biological function or its 
individual chemical structure. In addition, the method has high selectivity, hence 
high resolution, and usually high capacity for proteins of interest. (Amersham 
Pharmacia Biotech, 7) 
The interaction between a protein and a specific ligand coupled to a 
chromatographic matrix is reversible. The interaction can be a result of 
electrostatic or hydrophobic interactions, van der Waals’ forces and/or hydrogen 
bonding. Typical examples of specific interaction partners are: enzyme-
substrate complex, antigen-antibody reaction, hormone-receptor binding, base 
pairing of nucleotides and metal ions with histidine tagged proteins. (Turpeenoja 
2005, 180; Amersham Pharmacia Biotech, 9)  
Because the interaction between the target proteins and the affinity matrix is 
specific, all the contaminating molecules will run through the chromatography 
column leaving only the target proteins into the column. Depending of the wash 
condition, also proteins specifically interacting with the target may be retained. 
The target proteins can be then eluted from the affinity medium by reversing the 
interaction, either specifically using a competitive ligand or non-specifically, by 
changing the pH, ionic strength or polarity. (Amersham Pharmacia Biotech, 9; 
Puig – Caspary – Rigaut – Rutz – Bouveret – Bradago – Nilsson – Wilm – 
Séraphin 2001) The main stages of affinity chromatographic purification can be 
seen in figure 4 below. 
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FIGURE 4. Typical affinity purification. (Amersham Pharmacia Biotech) 
3.3 Tandem affinity purification 
Tandem affinity purification (TAP) allows rapid purification with high yield of 
protein complexes under native conditions, even when expressed at their 
natural level. The purified complex can be used for protein identification, 
functional, or structural studies. (Puig et al. 2001, 218–219) 
The TAP method requires the fusion of the TAP tag to the protein of interest 
and the introduction of the construct to the host cell or organism. The 
composition of the TAP tag is two IgG binding sites of Staphylococcus aureus 
protein A (ProtA) and a calmodulin binding peptide (CBP). These binding sites 
are separated by a TEV protease cleavage site (see figure 5 A). (Puig et al. 
2001, 219) 
Various cell extraction procedures can be used depending on the target protein. 
The fusion protein as well as associating partners is then recovered from the 
extract by two specific affinity purification steps (see figure 5 B). The ProtA 
domain binds tightly to an IgG matrix and, thus, requires the use of TEV 
protease in order to elute material under native conditions. In the second affinity 
purification, the eluate of this first purification step is incubated with calmodulin-
coated beads in the presence of calcium. The bound material is then washed, 
which removes contaminants and the remaining TEV protease, and released 
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under mild conditions with EGTA (ethylene glycol tetraacetic acid). (Puig et al. 
2001, 219) 
 
FIGURE 5. (A) The C- and N-terminal TAP tag. (B) Brief overview of the TAP 
method. (Puig et al. 2001, 220) 
The material achieved by TAP method can be analysed in several ways. The 
TAP method can be used to purify recombinant proteins that are expressed at 
low levels. It can be used to analyse the activity of the purified complex or the 
structure providing that the purified complex is stable, sufficiently large and 
concentrated. However, the major application is to identify the proteins 
functionally interacting with the target protein. (Puig et al. 2001, 222–223) 
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3.4 Characterisation of proteins 
There are a lot of different types of methods to characterise proteins. It needs to 
be determined case by case which method to use and, therefore, only relevant 
methods are presented below. 
3.4.1 SDS-PAGE 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) is a 
technique to characterise proteins by separating them on a gel according to 
their size with the help of an electrical current. It is a very course technique and 
precise results cannot be achieved – the molecular weight can only be 
estimated. Very small amounts of protein can be analysed with it and, therefore, 
it will not waste the sample. 
Proteins are treated with SDS (sodium dodecyl sulphate) in order to make them 
negatively charged. The denaturing of the proteins is enhanced with fast 
heating and mercaptoethanol which breaks the disulphide bridges. The proteins 
are then run on a polyacrylamide gel. An electrical current is applied and the 
molecules move towards the oppositely charged pole. The smaller the 
molecule, the faster it moves and the further it gets in the gel. Finally, the 
protein bands are visualised by staining the gel. Usually Coomassie Brilliant 
Blue and silver staining is used. With Coomassie, staining bands containing 2 
µg of protein can be made visible. Silver staining is a more sensitive technique 
which allows bands containing few nanograms of protein to be made visible. 
A molecular marker is usually run along with the samples. It contains proteins 
with known masses which allow the approximate determination of the sizes of 
the sample proteins. (Turpeenoja 1999, 178–190) The proteins can also be 
further analysed for example with western blotting or mass spectrometry. 
3.4.2 Western blotting 
After separating proteins using SDS-PAGE, specific proteins can be identified 
by western blotting. The proteins are transferred from the gel onto a 
nitrocellulose or an alternative polymer membrane with the help of an electrical 
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current. Once transferred onto the membrane, proteins can be examined using 
antibodies that interact specifically with the protein(s) of interest. The membrane 
is first incubated in a protein solution which will block all the areas on the 
membrane where no proteins from the sample are present. The membrane is 
then incubated in a solution containing the primary antibody directed against the 
protein(s) of interest. After this, the membrane needs to be incubated further 
with a secondary antibody against the primary antibody. This secondary 
antibody contains a label in order for the reaction to be detectable. Usually 
enzyme-linked antibodies are used. The membrane is incubated with a 
substrate which is converted into a coloured product or fluorescence by the 
enzyme-label. The coloured band therefore indicates that the protein(s) of 
interest is present. (Wilson – Walker 2010, 419–420) 
3.4.3 Mass spectrometry 
Mass spectrometry is an analytic technique with which the masses of individual 
molecules and atoms can be determined. It probably is the most versatile and 
comprehensive analytic technique used by chemists and biochemists. By the 
lack of a suitable ionization technique, there were not applications of mass 
spectrometry for samples of a biological origin in the past. But the situation 
changed as several gentler modes of ionisation were developed including fast-
atom bombardment (FAB), electrospray ionisation (ESI) and matrix assisted 
laser desorption/ionisation (MALDI). These ionisation techniques allowed the 
production of ions from non-polar compounds, compounds of large molecular 
mass and compounds of biological relevance. (Dass 2001, 2–3) 
The first essential step in a mass spectrometry analysis is to convert the analyte 
molecules into gas-phase ions in order to be detectable. The excess energy 
presented into the analyte during ionisation leads to fragmentation of the ion. 
These molecular ions and their charged fragments are then separated 
according to their m/z (mass/charge) ratio and their ion current is detected by a 
suitable detector. A high vacuum is applied under all these steps to enable the 
ions to move freely without colliding or interacting with other species. Finally, a 
mass spectrum is displayed on the basis of the information achieved. (Dass 
2001, 3) 
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There are numerous different ionisation techniques available but in this work the 
MALDI technique was used. In the MALDI technique the sample is ionised 
using an intense laser beam. It deposits a large amount of energy into the 
sample molecules for their desorption into the gas phase. The use of a matrix 
allows a large amount of energy to be absorbed efficiently by the matrix and 
subsequently transferred into the sample in a controlled manner. This leads to 
the evaporation of the matrix and the analyte with the matrix and as a 
consequence the analyte molecules become ionised. (Dass 2001, 26–27) 
The most important property of the matrix is that it absorbs energy at the 
wavelength of the laser radiation. Other desirable characteristics are the ability 
to form microcrystals with the sample and a low sublimation temperature. Time 
of flight (TOF) instruments are commonly used in the applications of MALDI 
because the pulsed nature of the laser beam matches well with the pulsed 
scanning mode of TOFMS. (Dass 2001, 29) Also in this work, TOF was used 
with MALDI. 
 
FIGURE 6. A simple illustration of MALDI-TOFMS (Dass 2001, 29) 
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4 EXPERIMENTAL PART 
The aim was to purify Rpm2p protein which is a yeast protein associated with 
the mitochondrial FAS.  The first purification was made using yeast cell extracts 
and the second purification using mitochondrial extracts. By using a mildly 
modified procedure, recovery of the protein and associated factors from the 
extracts with IgG columns eluting with self-made tobacco etch virus (TEV) 
protease was performed (van den Berg – Löfdahl – Berglund 2006). A control 
construct encoding tagged glycine cleavage system H protein Gcv3p was run in 
parallel to test specificity of the purification. Interactions of Gcv3p with other 
proteins were also a topic of interest. 
4.1 Production and purification of TEV protease 
First, the His-tagged TEV protease was produced in a BL21(DE3)pLysS RARE 
pTH24:TEVsh E. coli strain, isolated and then purified using affinity 
chromatography (van den Berg – Löfdahl – Berglund 2006). The self made 
protease was then later used for the cleavage of the TAP tags of the target 
proteins by TEV elution. The gene expression was induced with IPTG and the 
cells were then broken by sonication. 
4.1.1 Growing cultures and the induction of the gene expression 
First, 50 ml of LB (see appendix 1) with chloramphenicol (34 mg/ml) and 
carbenicillin (50mg/ml) was inoculated with BL21(DE3)pLysS RARE 
pTH24:TEVsh and cultured overnight at +37oC. 10 ml of this overnight culture 
was then used to inoculate a litre culture the next day. M9ZB medium (see 
appendix 1) with chloramphenicol (34 mg/ml) and carbenicillin (50 mg/ml) was 
used in the litre culture. The culture was incubated at +37oC until the OD600 
reached 0.420 and was then transferred into a +20oC incubator. As the OD600 
reached 0.610, the gene expression was induced by addition of IPTG to a final 
concentration of 0.1 mM. The induction was continued for ~20 hours at +20oC. 
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4.1.2 Harvesting and breaking the cells 
The cells were harvested by centrifuging for 25 minutes at 4200 rpm, +4oC 
(rotor 4.2). The supernatant was discarded and the cells were washed with 50 
ml of 1 x PBS (see appendix 1). The cell suspensions were then divided in two 
50 ml Falcon tubes, centrifuged for 10 minutes at full speed with a table top 
centrifuge and the supernatants were discarded. The cells were then frozen at -
70 oC until the experiment was continued. 
The frozen cell pellets were thawed out on ice and the approximate pellet 
weight was determined. The pellet was re-suspended in 5ml/g of cold lysis 
buffer (see appendix 1). Lysozyme was added to a concentration of ~0.3 mg/ml 
and the suspensions were then incubated 30 min on ice. The cell suspensions 
were sonicated 7x20 seconds holding 10 second breaks in between while 
cooling in ice water. Cell debris was removed by centrifugation at 15000 x g, 
+4oC for 30 min using the SS-34 rotor. 
4.1.3 Purification of TEV protease 
The supernatant achieved from the breaking of cells was mixed gently with 8 ml 
of equilibrated 50 % Ni-NTA Superflow slurry (Qiagen) for 1 h at +4oC. The 
resin was packed into a washed column and the column flow through was 
collected. The column was washed with the wash buffer (see appendix 1) to 
remove contaminating E. coli proteins and the His-tagged TEV protease was 
eluted with the elution buffer (see appendix 1). 
EDTA and DTT were added into the eluate to the final concentration of 2 and 10 
mM, respectively. 10 ml of the eluate was then dialysed against 1 l of the 
dialysis buffer (see appendix 1) overnight at +4oC. After removal of any 
precipitate by centrifugation at 14000 x g for 20 min the protease concentration 
was determined with NanoDrop 1000. For storage glycerol was added to a final 
concentration of 10 %. The samples were then flash frozen in liquid N2 and 
stored at -70oC. 
All the samples collected during the purification procedure were run on a 15 % 
SDS-PAGE gel at 150 V for 55 min to analyse the purity of the protease. 
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Fermentas PageRulerTM Prestained Protein Ladder was run along with the 
samples (see appendix 2). The gel was then stained with Coomassie Brilliant 
Blue and dried. 
4.2 Detection of Rpm2p 
Before starting the purifications of the target protein, it is needed to test if the 
protein Rpm2p is detectable. In order to test it, 100 ml cultures were grown and 
samples taken at certain OD600 values. The proteins were then extracted by 
TCA-precipitation (trichloroacetic acid) and the samples were run on a SDS-
PAGE identified by western blotting. 
4.2.1 Growing cultures 
At first, 5 ml cultures of W1536 5B (control strain) in SCD medium (see 
appendix 1), W1536 5B+YCpIIIRPM2+TAPtag (wt) in SCD-LEU medium (see 
appendix 1) and BY4741Δrpm2+YCpIIIRPM2+TAPtag in SCD-LEU medium 
were grown overnight at +30 oC and used to inoculate 100 ml cultures the next 
day. The 100 ml cultures were grown overnight and a 10 ml sample of each 
culture was taken for protein extraction. 5 ml of the overnight cultures were 
used to inoculate 100 ml cultures. Samples were taken at certain OD600 values: 
a 50 ml sample at OD600 ~1 and a 25 ml sample at OD600~2. Later it was noticed 
that the measurements of the OD600 were done incorrectly and therefore the 
OD600 values of the samples were probably much greater (1.5-2x) than 
intended. 
4.2.2 Protein extraction from yeast by TCA-precipitation 
The cells were harvested by centrifugation at 3 000 x g, +4 oC for 5 min with a 
table top centrifuge and washed with 25 ml of sterile water. 1 ml of sterile water 
was added and the cell suspensions were transferred into pre-weighed 
Eppendorf tubes. After centrifuging for ~10 seconds at full speed, the 
supernatant was discarded. The centrifugation was repeated and the rest of the 
supernatant was carefully withdrawn with a pipette and discarded. The pellet 
weight was then determined and 1 ml sterile water was added per 100 mg of 
cells. 300 µl (~30 mg) of the cell suspensions were transferred into fresh 
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Eppendorf tubes and 15 µl of 1 M KPi (potassium phosphate) buffer pH 7.4 was 
added and mixed. 100 µl of 50 % TCA was added and mixed and the tubes 
were stored at -70 oC until use. Freezing in TCA aids the cell disruption. 
The cells were thawed and centrifuged for 10 min at full speed. After discarding 
the supernatant the pellets were washed with ice-cold 80 % acetone and 
centrifuged for 5 min at full speed. The supernatant was discarded and the 
pellets were re-suspended in 60 µl 1 % SDS/ 0.1 M NaOH -solution. 20 µl of 4 x 
SDS-PAGE loading buffer containing 10 % mercaptoethanol was added and the 
samples were boiled 5 min at +95 oC. 
10 µl of each sample was run on a BIO-RAD Mini-Protean® TGXTM Any kDTM 
gel (10-well comb, 30 µl/well, Cat. #456-9033) at 150 V for 50 min. Fermentas 
PageRulerTM Prestained Protein Ladder was run along with the samples (see 
appendix 2). The proteins were then transferred onto a 0.2 µm nitrocellulose 
membrane (BIO-RAD Trans-Blot® TurboTM Transfer Pack, Mini Format, 0.2 µm 
Nitrocellulose, Single Application, Cat.#170-4158), using BIO-RAD Trans-Blot® 
TurboTM Transfer system. 
4.2.3 Western blotting 
The western blotting was done using Millipore Snap i.d. blotting system. The 
membrane was first blocked with 30 ml of Sigma’s 1 x blocking buffer (Cat# 
B6429-500ml). 3 ml of the 1:500 diluted primary antibody, rabbit-anti-goat-HRP, 
was incubated for 10 minutes on the membrane and washed three times with 
30 ml of TBS-Tween pH 7.4 (see appendix 1). Then the 1:5000 diluted 
secondary antibody, goat-anti-rabbit-HRP, was incubated for 10 minutes on the 
membrane and the membrane was then washed twice with 30 ml of TBS-
Tween pH 7.4 and once with 30 ml of TBS pH 7.4 (see appendix 1). 1.5 ml of 
peroxide solution and luminal/enhancer solution of BIO-RAD Immun-StarTM 
WesternCTM Kit (Cat.#170-5070) was mixed and incubated 5 minutes on the 
membrane. The detection was done using BIO-RAD Molecular Imager® 
ChemidocTM XRS+ with Image LabTM Software. 
 29 
4.3 First purification using solubilised extract 
The first purification of the proteins was made using solubilised total cell extract. 
The membrane protein complexes were first isolated from 2-3 g of cells using 
three different yeast strains. The isolated proteins were made soluble using 
Triton X-100, then bound to an IgG column and eluted with the self made TEV 
protease.  
4.3.1 Isolation of yeast proteins and solubilisation 
Cultures of 10 ml of the following yeast strains were grown overnight at +30oC 
shaker in SCD-LEU medium. 
 W1536 5BΔgcv3+YCpIIIGCV3+TAPtag (control) 
 W1536 5B+YCpIIIRPM2+TAPtag (wildtype) 
 W1536 5B+YCpIIIΔetr1+YCpIIIRPM2+TAPtag (Δetr1)  
These cultures were used for inoculating 50 ml cultures the next day. The 50 ml 
cultures were grown approximately 7 hours and 1 litre cultures were inoculated 
with these cultures and grown overnight.  
The cells were harvested centrifuging 30 min at 3000 x g, +4oC (rotor 4.2). 
Supernatant was discarded and the cells were re-suspended in the residual 
liquid. The cell suspensions were transferred into pre-weighed Falcon tubes and 
centrifuged for 5 min at 4100 x g, +4oC. The cells were washed twice with 25 ml 
of sterile water and centrifuged as previously. The wet weights of the pellets 
were determined and 2-3 g of cells per each yeast strain was taken for the 
extraction. 
The pellets were suspended in 9 ml of buffer 2 (see appendix) and 12 g of glass 
beads was added. The cells were homogenized in a bead beater and the beads 
were spun down with a table top centrifuge. 9 ml of the supernatant was 
transferred into ultracentrifuge tube and centrifuged for 1 hour at 38 000 rpm, 
+4oC (rotor 70.1 Ti). The pellet was suspended in 1 ml of buffer 2 with a Potter 
homogenizer (15 strokes, 500 rpm). The absolute protein concentration of the 
solution was determined with NanoDrop (Thermo Scientific) and approximately 
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100 mg of protein per yeast strain was transferred into ultracentrifuge tubes. 
The volume was brought up to 4.25 ml with buffer 4 (see appendix 1) and 4.25 
ml of buffer 5 (see appendix 1) was added. The suspensions were incubated 1 
hour in a rotating shaker at +4oC and then centrifuged for 1 hour at 38 000 rpm, 
+4oC (rotor 70.1 Ti). The supernatants were transferred into fresh Falcon tubes. 
4.3.2 Affinity chromatography and TEV elution 
In order to bind the proteins to the IgG beads, 70 µl of IgG-sepharose (GE 
Healthcare) slurry equilibrated in buffer 4 per tube was added and incubated 
overnight at +4oC rotating shaker. The beads were spun down and the 
supernatant was discarded carefully. The sepharose pellets were re-suspended 
in the residual liquid and transferred into Mobicol spin columns (Mobitech 
GmbH, Göttingen, Germany) equilibrated with buffer 5. The columns were 
washed with 250 µl and 200 µl of buffer 5 which is the flow through and again 
with 10 x 350 µl. 
Then 3 µl of the self-made TEV protease and 73 µl of buffer 5 was added to 
each column and mixed carefully. After incubating 2 hours at +16oC, the 
columns were centrifuged and washed twice with 40 µl of buffer 5. The fractions 
of each column were frozen in liquid N2 as 4 aliquots of 39 µl and stored at -70 
oC (total volume ~156 µl). After centrifuging the columns, 350 µl of 1 x SDS-
sample buffer was added to each column and centrifuged. This was repeated 
with 350 µl. 
All the samples collected were run on a BIO-RAD Mini-Protean® TGXTM Any 
kDTM gel (10-well comb, 30 µl/well, Cat. #456-9033), control samples at 200 V 
for 28 min and the rest of the samples at 200 V for 45 min. The gels were then 
silver stained and dried. Fermentas PageRulerTM Prestained Protein Ladder 
was run along with the samples (see appendix 2). 
4.4 Second purification using purified mitochondria 
The second purification was carried out using purified mitochondria. First, the 
crude mitochondrial fraction was prepared. In order to remove contamination by 
ER or vacuole, the mitochondrial fraction was purified using a sucrose gradient. 
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The purified mitochondria were then solubilised using Triton X-100 and the 
proteins bound to IgG-sepharose column. The proteins of interest are eluted 
with the self-made TEV protease. 
4.4.1 Isolation of crude mitochondrial fraction 
Pre-cultures of 10 ml of yeast strains W1536 5BΔgcv3+YCpIIIGCV3+TAPtag 
(control) and W1536 5B+YCpIIIRPM2+TAPtag (wildtype) were inoculated and 
cultured overnight in SCD-LEU medium at +30oC shaker. With these 10 ml 
cultures 50 ml cultures were inoculated and cultured overnight. The next day 1 
litre cultures were inoculated and cultured for approximately 10 hours until they 
had reached OD600 values of 3.48 (gcv3) and 3.31 (rpm2). 
The cells were harvested in 1 litre centrifuging bottles at 4 000 rpm, +4 oC for 30 
min. The cell pellets were then transferred into pre-weighed Falcon tubes and 
washed with 25 ml of sterile water. After centrifuging at 3 000 x g for 5 min the 
wet pellet weight was determined. The pellets were re-suspended in 2 ml of 
DTT buffer per g of cells and incubated 20 minutes in a +30 oC shaker (slow 
speed ~100 rpm). The cells were then centrifuged for 5 min at 3 000 x g and the 
supernatant was discarded. Zymolyase buffer (see appendix 1) was added up 
to 25 ml and in which the cells were re-suspended. The supernatant was 
discarded after centrifuging 5 min at 3 000 x g and the cells were re-suspended 
in 7 ml of zymolyase buffer per g of cells. Also 7 mg of Zymolyase-20T 
(Seikagaku Kogyo Co.) per g of cells was added and mixed carefully. The cells 
were then incubated 45 min at +30 oC shaker (100 rpm). 
The cell suspensions were centrifuged for 5 min at 3 000 x g and the 
supernatant was discarded. From this point on all the steps were done on ice in 
order to prevent the degradation of the protein. Ice-cold homogenisation buffer 
(see appendix 1) was added up to 25 ml and after adding 250 µl of PMSF 
(phenylmethylsulfonyl fluoride) to the concentration of 1mM the cells were 
broken immediately in a glass potter with 15 strokes at 500 rpm. The cell 
suspensions were transferred back into the Falcon tubes and centrifuged for 5 
min at 1 500 x g, +4 oC. The supernatant was then transferred into a fresh 
Falcon tube and centrifuged for 10 min at 3 000 x g, +4 oC. The supernatant 
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was transferred into ultracentrifuge tubes and centrifuged for 15 min at 12 000 x 
g, +4 oC. The pellet was re-suspended into 10 ml of ice-cold SEM buffer (see 
appendix 1) and then treated with 10 strokes in a glass potter at 500 rpm. 
4.4.2 Sucrose gradient 
The sucrose gradients were loaded into tubes using a pump to slowly drain the 
layers on top of each other. The homogenate was then carefully loaded on top 
of the sucrose gradients using the pump. The gradients were consisted of the 
following layers (starting from the bottom): 
 9 ml 60 % sucrose in EM buffer (see appendix 1) 
 24 ml 32 % sucrose in EM buffer 
 9 ml 23 % sucrose in EM buffer 
 9 ml 15 % sucrose in EM buffer 
The tubes were then balanced carefully and centrifuged for 1 hour at 41 400 
rpm, +2 oC. After centrifugation the purified mitochondria were collected from 
the 60 % and 32 % interface. Also the mitochondria on the walls were collected. 
The volume of the mitochondria was assessed and an equal amount of SEM 
buffer was added. The mixture was then centrifuged for 15 min at 10 000 x g, 
+4 oC. The supernatant was discarded and the pellet was re-suspended into 1 
ml of SEM buffer. The mitochondria suspension was transferred into a pre-
weighed Eppendorf tube and centrifuged for 10 min at full speed at +4 oC. The 
wet pellet weight was determined and the pellet was frozen in liquid N2. The 
pellet was stored at -70 oC. 
4.4.3 Solubilisation 
The mitochondrial pellets were thawed on ice and re-suspended in 1 ml of 
buffer 4. The absolute protein concentration was determined with NanoDrop 
and approximately 40 mg of protein was transferred into ultracentrifuge tubes. 
The volume was brought up to 8.5 ml with buffer 4 and the tubes were 
incubated 1 hour at +4 oC in a rotating shaker. After balancing the tubes they 
were centrifuged for 1 hour at 38 000 rpm, +4 oC (rotor 70.1 Ti). 
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4.4.4 Affinity chromatography and TEV elution 
At first 35 µl of the IgG-sepharose slurry per 15 ml Falcon tube was equilibrated 
with buffer 4. The supernatant achieved from the solubilisation was then 
transferred into the tube containing equilibrated IgG-sepharose. The tubes were 
incubated overnight at +4 oC in a rotating shaker. 
In order to remove the supernatant the tubes were centrifuged for 5 min at 
1 500 x g. Approximately 500 µl of the supernatant was left for re-suspension. 
The sepharose pellets were transferred into Mobicol columns equilibrated with 
buffer 5 and centrifuged for 1 min at 200 rpm. The columns were washed 10 
times with 175 µl of buffer 5. 
Then 1.5 µl of the self-made TEV protease and 73.5 µl of buffer 5 was added 
into the column and carefully mixed. The columns were incubated 2 hours at 
+16 oC. After the incubation the columns were centrifuged (1 min at 200 rpm) 
and washed twice with 37.5 µl of buffer 5. The fractions were frozen in liquid N2 
as four aliquots of 37.5 µl each (total volume 150 µl) and stored at -70 oC. 
Lastly, the column was eluted with 170 µl and 100 µl of 1 x SDS-sample buffer. 
All the samples collected were run on a BIO-RAD Mini-Protean® TGXTM Any 
kDTM gel (10-well comb, 30 µl/well, Cat. #456-9033) at 200 V for 27 min. The 
gels were then silver stained and dried. Fermentas PageRulerTM Plus 
Prestained Protein Ladder was run along with the samples (see appendix 2). 
4.5 Preparation of samples for MALDI-TOF mass analyser 
The samples from the first purification and the second purification were 
prepared in a similar way for the mass analyser. Only different matrix solutions 
were used. 
Bands of interest and a blank were cut from the silver stained SDS-PAGE gel. 
The gel pieces were transferred into Eppendorf tubes and destained by adding 
100 µl of a solution containing 1 part of sodium thiosulphate and 1 part of 
potassiumhexacyanoferrat and incubating 10 min at room temperature. After 
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removing the destaining solution they were washed three times with 200 µl of 
sterile water until they were no longer yellow. 
100 µl of 40 % acetonitrile (AcN), 0.2 M NH4HCO3 and 2 µl of 1 M DTT was 
added and incubated 1 hour at +37 oC heating block. The solution was removed 
and 100 µl of 40 % AcN, 0.2 M NH4HCO3 and 5 µl of 1M IAA was added and 
incubated 1 hour at a +37 oC heating block. The gel pieces were then washed 
with 200 µl of 40 % AcN, 0.2 M NH4HCO3 and dehydrated with 50 µl of 100 % 
AcN. After removing the AcN solution they were dried and cooled on ice. The 
gel pieces were soaked with trypsin solution (20 ng of trypsin per sample) and 
first incubated 30 min on ice and then overnight at a +37 oC heating block. 
The next day 20 µl of 30 % AcN/ 0.5 % TFA (trifluoroacetic acid) was added and 
incubated 5 min in an ultrasonic bath. The 20 µl was transferred into a fresh 
Eppendorf tube and 20 µl of 70 % AcN/0.1 % TFA was added on the gel piece 
and incubated in an ultrasonic bath as previously. The two 20 µl extractions 
were pooled and dried under vacuum in a speed-vac for 30 min. 5 µl of TA30 
was added to each sample and incubated 2 hours in a shaker at room 
temperature.  
4.6 Analysing samples with MALDI-TOF mass analyser 
The samples from the second purification were analysed on a different plate 
than the samples from the first purification. A ground steel plate was used for 
samples from the first purification and an anchored-chip-plate for samples from 
the second purification. 
4.6.1 Samples from the first purification 
Samples were mixed 1:1 with HCCA (α-cyano-4-hydroxy cinnamic acid) matrix 
solution. Each sample was then pipetted on a ground steel plate and analysed 
with the mass analyser using dried droplet protocol which enables fast, simple 
and robust MALDI preparation of virtually all types of samples. 
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4.6.2 Samples from the second purification 
Samples were first pipetted on the anchor chip plate, which concentrates the 
sample on the plate and, thus, enhances the analysing of samples of low 
concentration. The samples were dried and then the TFA matrix was pipetted 
on top of the sample. All the samples were then analysed with the mass 
analyser. 
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5 RESULTS 
In this section, results from the experimental part of the thesis are presented. 
Pictures of SDS-PAGE gels, western blots etc. from the experiments are 
explained and only the results significant for this thesis are summarised. 
5.1 Production and purification of TEV protease 
The purity of the TEV protease was monitored by taking samples before, during 
and after the purification procedure and running them on a SDS-PAGE gel. As 
seen on the Coomassie stained gel (figure 7), the purity of the protease 
increases significantly along the way. TEV is the size of 34 kDa. The band of 
TEV protease after dialysis is very intense and there are hardly any 
contaminants. 
In order to know whether the protease is active, it should have been tested 
using a suitable substrate to this enzyme. Because of lack of a substrate, the 
protease was not tested before use. However, the TEV protease has been 
purified in this manner numerous times by Dr. Tiila Kiema in the Wierenga 
laboratory at the Biochemistry Department Oulu. 
 
FIGURE 7. Samples of the purification of TEV protease on a SDS-PAGE gel. 
(1.) Lysate supernatant (2.) lysate supernatant (3.) flow through (4.) wash 
(5.)eluate (6.) dialysed TEV. 
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5.2 Detection of Rpm2p 
The protein was extracted from the cultures by TCA precipitation and separated 
on a SDS-PAGE gel. A western blot was then done for the protein using 
antibodies against the Prot-A of the TAP tag on the protein. The detection was 
remarkably difficult as the protein is of low abundance but after several western 
blots a weak band of the Rpm2p protein was detected. As seen in figure 8, the 
band for the wt is poorly noticeable but it can be confirmed that the protein is 
detectable and the project could be continued. The control strain was later 
changed to another strain and therefore the results related to the control strain 
used in this experiment are not important. 
 
 
 
FIGURE 8. Western blot of the Rpm2p protein. 
 
5.3 First purification using solubilised extract 
Samples were collected during the protein extraction and the purification of the 
protein. These samples were then run on SDS-PAGE gels and the gels were 
silver stained. In figure 9 are the samples of the control strain, in figure 10 
samples of the Δetr1 strain and in figure 11 samples of the wildtype strain. The 
samples of wildtype and Δetr1 strains were run for a bit too long and therefore 
the three last bands of the molecular weight marker and some of the proteins of 
the samples (smaller than 26 kDa in size) were run off the gel. The highest 
band of the molecular weight marker is 170 kDa. The strong band in lanes 8 
and 9 is the TEV protease in all the three gels. 
 
 
 wt Δrpm2 
170 kDa 
130 kDa 
 OD1 OD2 O/N OD1 OD2 O/N 
 38 
 
FIGURE 9. Samples of the control strain on a silver stained SDS-PAGE gel. (1.) 
homogenate (2.) supernatant after the first ultracentrifugation (3.) pellet after the 
first ultracentrifugation (4.) supernatant after the second ultracentrifugation (5.) 
pellet after the second ultracentrifugation (6.) flow through (7.) wash (8.) SDS-
elution (9.) fraction from the TEV elution. 
 
FIGURE 10. Samples of the Δetr1 strain on a silver stained SDS-PAGE gel. (1.) 
homogenate (2.) supernatant after the first ultracentrifugation (3.) pellet after the 
first ultracentrifugation (4.) supernatant after the second ultracentrifugation (5.) 
pellet after the second ultracentrifugation (6.) flow through (7.) wash (8.) SDS-
elution (9.) fraction from the TEV elution. 
TEV (34 kDa) 
TEV (34 kDa) 
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FIGURE 11. Samples of the wildtype strain on a silver stained SDS-PAGE gel. 
(1.) homogenate (2.) supernatant after the first ultracentrifugation (3.) pellet 
after the first ultracentrifugation (4.) supernatant after the second 
ultracentrifugation (5.) pellet after the second ultracentrifugation (6.) flow 
through (7.) wash (8.) SDS-elution (9.) fraction from the TEV elution. 
 
Fractions of all of the strains from the TEV elution were run on a bigger SDS-
PAGE in order to get better separation of the proteins and more clear bands 
which could be then further analysed. The gel was then silver stained. The lane 
1 in figure 12 of the silver stained gel is the control strain, lane 2 is the wildtype 
strain and the lane 3 is the Δetr1 strain. The bands found most interesting were 
then analysed with the MALDI-TOF mass analyser. The bands of the three 
different strains were compared with each other and the bands with differences 
between the strains were chosen. The bands identified can be seen in figure 12. 
TEV (34 kDa) 
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FIGURE 12. Silver stained SDS-PAGE gel of all the fractions from TEV elution. 
The bands indicated were further analysed with MALDI-TOF. (1.) control strain, 
(2.) wildtype strain (3.) Δetr1 strain. 
The proteins of interest could not be traced with the mass analyser. The only 
discovery was the TEV protease which was found on the bands expected. All of 
these bands seen in the picture were identified as catalytically active Tobacco 
etch virus protease complexed with the product. The sizes of these bands on 
the gel are approximately around 34 kDa which is exactly the size of TEV 
protease. 
 1 2 3 
34 kDa 
26 kDa 
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5.4 Second purification using purified mitochondria 
Only the control strain and the wildtype strain were used for the second 
purification. Therefore the Δetr1 strain was left out because this strain was not 
the main interest and the other strains had to be concentrated on. 
The bands identified with the mass analyser can be seen in figure 13. Lane 1 is 
the SDS-elution sample and lane 2 is the fraction sample of the wt strain. Lane 
3 is the SDS-elution sample and lane 4 is the fraction sample of the control 
strain. The band b2 was identified to be Gcv3p. The size of the protein on the 
gel is approximately 36 kDa which is relatively big for Gcv3p because the 
evaluated size of it is 19 kDa. The size would perhaps better be equivalent to 
the size of Gcv3p with the TAP tag which is ~35 kDa or a Gcv3p dimer. But, in 
any case, the Gcv3p protein is present, it cannot be merely a coincidence. The 
high molecular weight band just above 130 kDa in lane 4 seems to be specific 
for the Gcv3p but, unfortunately, it could not be identified. 
The band b4 was identified to as catalytically active Tobacco etch virus 
protease complexed with the product. The size of the protein on the gel is 
between 28 kDa and 36 kDa which would correspond to the size of TEV 
protease which is 34 kDa. 
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FIGURE 13. The silver stained SDS-PAGE gel of the fractions from the TEV 
elution and SDS-elution of both the control and the wildtype strain. (1.) SDS-
elution of wt strain, (2.) fraction of wt strain, (3.)SDS-elution of control strain, (4.) 
fraction of control strain. 
36 kDa 
 
28 kDa 
130 kDa 
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6 DISCUSSION 
The purification of the produced TEV protease was successful in general. A 
very clear band was achieved in the Coomassie stained SDS-PAGE gel. There 
were hardly any contaminating proteins and if there were, the bands were very 
light commensurated to the bands of TEV protease. Even though the protease 
could not be tested properly, due to the lack of a substrate, it could be identified 
with the mass analyser. 
There were difficulties in detecting the Rpm2p protein. It could not be detected 
at all at the first attempts but after several western blots a weak signal was 
finally achieved. The reason why the signal was so weak might be because of 
the low abundance of the protein under the conditions examined. 
The first purification did not go as expected as the target proteins could not be 
tracked with MALDI-TOF. The low abundance of the Rpm2p and Gcv3p might 
be one reason also for this. The amount of the proteins produced in the cells is 
so small and therefore the purification method is not effective enough – too 
much contaminating protein is interfering and the target proteins are lost in the 
mix. This means that a more effective purification protocol must be used and 
therefore a second purification was done. Even though not being able to identify 
the target proteins the TEV protease was identified, as mentioned before, which 
confirmed it was what it should be and would compensate the failure of not 
been able to test it with substrate. 
The second purification was a bit more successful than the first purification as 
the control protein Gcv3p could be identified from the silver stained SDS-PAGE 
gel with the MALDI-TOF mass analyser. Although the target protein Rpm2p 
could not be purified and identified, the fact that the control protein could be 
identified would therefore state that the purification should work in general. It is 
interesting that Gcv3p ran at a size of about 36 kDa. This size corresponds to 
the TAP tagged Gcv3p monomer, but would also fit a Gcv3p dimer. As the 
protein A part was not identified in the Gcv3p band by mass spectrometry, and 
the protein was released in the TEV elution, it seems unlikely that the band 
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represents tagged Gcv3p. On the other hand, it is not clear how a Gcv3p dimer 
could resist the harsh conditions of SDS PAGE. Remarkably, a high molecular 
weight band apparently specific for the Gcv3p purification appeared in the Gcv3 
sample. Unfortunately, it was not possible to identify the protein represented by 
this band. 
The failure to isolate Rpm2p in the procedure leads to the question of why 
Rpm2p could not be purified even though a purified mitochondrial fraction was 
used. It might be that the protein is low abundant and gets lost in the mix of 
contaminating proteins. As in the western blots for the TAP tag of the Rpm2p, 
the signal achieved is very pale which tells there is not much protein in question 
in the sample. Nevertheless, there is Rpm2p in the sample. It is also possible 
that despite the use of detergent in the purification, a large part of the protein 
may remain in pelleted fractions as Rpm2p has been reported to be membrane 
associated. 
Another factor possibly interfering the purifying of Rpm2p, is the modification in 
the protocol as the pH was lowered down from 8 to 7. It could be that the lower 
pH is interfering the binding of the protein A to the IgG-matrix. This would mean 
that most of the protein would be left in the supernatant when incubating the 
solubilised extract with the IgG-beads. Of course the protein should then be 
able to be detected in the supernatant after taking the IgG-beads but the 
concentration of the protein in it is so low because of the high volume of the 
supernatant that it might not possible to be detected at all. In addition, the 
success of purifying Gcv3p would indicate that the tag is still bound even at pH 
7. It may be worthwhile to investigate growth conditions that allow detection of 
clearer amounts of Rpm2p. 
As Gcv3p can be isolated in this procedure, it may be possible to find and 
identify proteins physically interacting with Gcv3p. The fact that the other 
components of glycine cleavage system were not found, may indicate that the 
purification has to be optimized for the identification of interacting factors (e.g. 
variation of the detergent used). An improvement of this purification may yield in 
answers on what the role of Gcv3p is in lipoylation, for example if interactions 
with lipoyl transferases could be shown. This work will provide a good starting 
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point for optimization and further investigations while it was not possible to yield 
concrete results on Rpm2p modifications or Rpm2 and Gcv3p interactions.  
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APPENDICES 
Solutions used 
LB medium 
10 g Tryptone 
5 g Yeast extract 
10 g NaCl 
Add distilled water up to 1 litre and autoclave. 
SCD medium 
6.7 g Yeast Nitrogen base w/o amino acids (DIFCO) 
1. 92 g Synthetic Drop Out media supplement without Uracil (SIGMA) 
0.08 g Uracil 
20 g Glucose 
Add distilled water up to 1 litre and autoclave. 
SCD-LEU medium 
6.7 g Yeast Nitrogen base w/o amino acids (DIFCO) 
1.6 g Synthetic Drop Out media supplement without Leucine 
20 g Glucose 
Add distilled water up to 1 litre and autoclave. 
10 x M9-SALT 
10 g NH4Cl 
30 g KH2PO4 
31.77 g Na2HPO4 
Add distilled water up to 1 litre and autoclave.
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M9ZB medium 
10 g Casein hydrolysate 
5 g NaCl 
Add 890 ml distilled water and autoclave. 
Before use add: 
100 ml 10 x M9-SALT 
10 ml sterile 85 % glycerol 
2 ml sterile 1 M MgSO4 
Lysis buffer 
50 mM NaH2PO 
300 mM NaCl 
10 mM imidazole (added just before use) 
Adjust pH to 8.0 using NaOH 
Wash buffer 
50 mM NaH2PO 
300 mM NaCl 
20 mM imidazole (added just before use) 
Adjust pH to 8.0 using NaOH 
Elution buffer 
50 mM NaH2PO 
300 mM NaCl 
250 mM imidazole (added just before use) 
Adjust pH to 8.0 using NaOH 
Dialysis buffer 
25 mM Tris, pH 8.0 at 4 oC 
150 mM NaCl 
2 mM EDTA 
2 mM DTT
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10 x Lysis buffer (buffer 1) 
0.2 M HEPES 
1 M Potassium acetate 
50 mM Magnesium acetate   
Adjust pH to 7.0 with KOH at 4 oC 
1 x Lysis Buffer + inhibitors (buffer 2) 
1 x Lysis buffer 
Inhibitors (1 tablet per 10 ml) 
1 mM PMSF 
10 mM EDTA 
Chech pH at 4 oC 
Solubilisation buffer (buffer 3) 
1 x Lysis buffer 
10 % (w/v) Glycerol 
10 mM EDTA 
Chech pH at 4 oC 
Solubilisation buffer + inhibitors (buffer 4) 
1 x Lysis buffer 
Inhibitors (1 tablet per 10 ml) 
1 mM PMSF 
10 mM EDTA 
10 % (w/v) Glycerol 
Chech pH at 4 oC 
Solubilisation buffer + inhibitors + Triton X-100 (buffer 5) 
1 x Lysis buffer 
Inhibitors (1 tablet per 10 ml) 
1 mM PMSF 
10 mM EDTA 
1 % Triton X-100 
10 % (w/v) Glycerol 
Chech pH at 4 oC 
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PBS 
137 mM NaCl 
2.7 mM KCl 
10 mM Na2HPO4 
2 mM KH2PO4 
Adjust pH to 7.4 
TBS 
20 mM Tris-HCl, pH 7.6 
137 mM NaCl 
TBS-Tween 
20 mM Tris-HCl, pH 7.6 
137 mM NaCl 
0.1 % Tween 20 
Zymolyase buffer 
1.2 M Sorbitol 
20 mM Potassium phosphate, pH to 7.4 
Homogenisation buffer 
0.6 M Sorbitol 
10 mM Tris-HCl, pH 7.4 
1 mM EDTA 
0.2 % (w/v) BSA 
SEM 
250 mM Sucrose 
1 mM EDTA 
10 mM Mops, pH 7.2 
EM 
10 mM Mops, pH 7.2 
1 mM EDTA 
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